Transformable hybrid semiconducting polymer nanozyme for second near-infrared photothermal ferrotherapy
Yuyan Jiang,
Xuhui Zhao,
Jiaguo Huang,
Jingchao Li,
Paul Kumar Upputuri,
He Sun,
Xiao Han,
Manojit Pramanik,
Yansong Miao,
Hongwei Duan,
Kanyi Pu () and
Ruiping Zhang ()
Additional contact information
Yuyan Jiang: Nanyang Technological University
Xuhui Zhao: The Affiliated Bethune Hospital of Shanxi Medical University
Jiaguo Huang: Nanyang Technological University
Jingchao Li: Nanyang Technological University
Paul Kumar Upputuri: Nanyang Technological University
He Sun: Nanyang Technological University
Xiao Han: Nanyang Technological University
Manojit Pramanik: Nanyang Technological University
Yansong Miao: Nanyang Technological University
Hongwei Duan: Nanyang Technological University
Kanyi Pu: Nanyang Technological University
Ruiping Zhang: The Affiliated Bethune Hospital of Shanxi Medical University
Nature Communications, 2020, vol. 11, issue 1, 1-13
Abstract:
Abstract Despite its growing promise in cancer treatment, ferrotherapy has low therapeutic efficacy due to compromised Fenton catalytic efficiency in tumor milieu. We herein report a hybrid semiconducting nanozyme (HSN) with high photothermal conversion efficiency for photoacoustic (PA) imaging-guided second near-infrared photothermal ferrotherapy. HSN comprises an amphiphilic semiconducting polymer as photothermal converter, PA emitter and iron-chelating Fenton catalyst. Upon photoirradiation, HSN generates heat not only to induce cytotoxicity but also to enhance Fenton reaction. The increased ·OH generation promotes both ferroptosis and apoptosis, oxidizes HSN (42 nm) and transforms it into tiny segments (1.7 nm) with elevated intratumoral permeability. The non-invasive seamless synergism leads to amplified therapeutic effects including a deep ablation depth (9 mm), reduced expression of metastasis-related proteins and inhibition of metastasis from primary tumor to distant organs. Thereby, our study provides a generalized nanozyme strategy to compensate both ferrotherapy and phototherapeutics for complete tumor regression.
Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (4)
Downloads: (external link)
https://www.nature.com/articles/s41467-020-15730-x Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15730-x
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-020-15730-x
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().